Latest Strategic Collaboration News

Nimy Resources has defined a high-grade gallium Exploration Target in Western Australia and secured strategic partnerships to support supply to the US Department of Defense, positioning itself strongly in the critical minerals sector.

FBR Limited wraps up its US Demonstration Program, secures $6.3 million in capital, and appoints Mark Pivac as CEO amid a 70% cost reduction drive. Strategic collaborations with Samsung Heavy Industries and Liebherr signal broader automation ambitions.

Invion Limited has progressed its Photosoft clinical programs with new patient dosing and an expanded collaboration with Hanlim Pharm, backed by a successful $2 million share placement to accelerate development.

4DS Memory Limited has successfully manufactured its first 20nm memory cell array, marking a pivotal step in its ReRAM technology development, while raising $8.6 million through a placement and Share Purchase Plan to fuel ongoing innovation.

Emmerson Resources has significantly expanded its White Devil gold resource by 25% to over 611,000 ounces, driving a 162% increase in the total Tennant Creek resource base. Meanwhile, commissioning of the Nobles CIL processing plant is ahead of schedule, setting the stage for imminent gold production.

NoviqTech has advanced its blockchain-based sustainability solutions, pioneering real-world asset tokenisation and expanding its investor base through OTCQB trading in the US.

Norwood Systems has landed a significant five-year contract with Optus to overhaul its voicemail platform, delivering early milestones on schedule and strengthening its financial position. The company is also advancing its global pipeline with Tier-1 telecom operators and deepening strategic partnerships with Microsoft Azure and AWS.

IPB Petroleum Limited has secured a crucial two-year extension on its WA-424-P permit in the Browse Basin, enabling continued exploration and development of its Gwydion asset while maintaining a solid cash position of AUD 1.487 million.

Argent BioPharma reports significant operational savings through manufacturing outsourcing, encouraging Phase IIb results for CimetrA®, and key regulatory approvals for cannabinoid therapies in Germany.

Odyssey Gold Limited has made significant strides in its Tuckanarra Gold Project during the March 2025 quarter, completing a regional airborne electromagnetic survey and signing a joint venture Memorandum of Understanding for ore processing. The company also initiated a technical study and appointed Matthew Syme as Executive Director.

Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.

Noxopharm Limited has successfully cleared key preclinical hurdles for its SOF-SKN™ lupus drug and expanded its Sofra™ platform collaborations, supported by fresh funding to propel upcoming clinical trials.